PTC Therapeutics Executive and Leadership Team

Nilam Mistry, the Chief Information Officer & Senior VP at PTC Therapeutics, directs the enterprise-wide digital infrastructure and data security protocols. Mistry architects scalable cloud solutions to support the biopharmaceutical research pipeline, ensuring seamless integration between laboratory data systems and global manufacturing operations. By optimizing internal network performance, the Chief Information Officer & Senior VP facilitates rapid information exchange across international research hubs. Nilam Mistry also manages the cybersecurity framework protecting proprietary drug development data. This leadership role involves aligning technological investments with the long-term commercialization goals of the company. Through the implementation of advanced analytics platforms, Mistry drives operational efficiency across the entire organization. The Chief Information Officer & Senior VP maintains robust digital compliance standards, supporting the delivery of orally administered small molecule drugs to patients worldwide while ensuring data integrity remains a top priority for the firm.

Linda Montella-Carter, the Chief Information Officer & Senior VP at PTC Therapeutics, oversees the strategic deployment of business intelligence tools and enterprise resource planning systems. Montella-Carter focuses on the modernization of clinical trial management software, enabling real-time data accessibility for research teams. By streamlining digital workflows, the Chief Information Officer & Senior VP enhances the speed of post-transcriptional control process analysis. Linda Montella-Carter also leads the integration of automated supply chain tracking to support the distribution of Translarna. This role requires constant collaboration with clinical development departments to ensure technological readiness for new drug launches. Through the management of large-scale IT projects, Montella-Carter improves cross-functional communication and operational agility. The Chief Information Officer & Senior VP ensures that all digital assets align with the company's mission to provide life-changing therapies, ultimately strengthening the technological foundation required for sustained growth in the competitive biopharmaceutical market.

Daphny Massingale, the Senior Director, Chief of Staff and Commercial Operations- North America at PTC Therapeutics, manages the execution of commercial strategies across the North American market. Massingale coordinates cross-departmental initiatives to ensure the successful delivery of small molecule drugs to ambulatory patients. By overseeing regional sales operations, the Senior Director, Chief of Staff and Commercial Operations- North America optimizes market access and patient support programs. Daphny Massingale also facilitates communication between executive leadership and field teams to maintain alignment with corporate objectives. This leadership role involves analyzing market trends to refine commercial tactics and improve patient outcomes. Through the management of operational resources, Massingale drives revenue growth and enhances the company's footprint in the rare disease sector. The Senior Director, Chief of Staff and Commercial Operations- North America ensures that all commercial activities adhere to regulatory standards while maximizing the impact of the company's therapeutic portfolio.

Meghan Schwarzenbek, the Chief of Staff To the Chief Information Officer at PTC Therapeutics, manages the strategic priorities and administrative operations within the information technology division. Schwarzenbek coordinates high-level projects that support the development of biopharmaceutical data infrastructure. By facilitating communication between the Chief Information Officer and other department heads, the Chief of Staff To the Chief Information Officer ensures that technological initiatives remain synchronized with the company's research goals. Meghan Schwarzenbek also oversees the allocation of departmental resources to maximize efficiency in digital transformation efforts. This role involves monitoring project timelines and identifying potential bottlenecks in the implementation of new software solutions. Through the management of executive workflows, Schwarzenbek enables the IT leadership team to focus on long-term innovation. The Chief of Staff To the Chief Information Officer plays a vital role in maintaining organizational cohesion, ensuring that all technology-driven projects contribute directly to the success of the company's drug discovery pipeline.

Quintus Ngumah, the Vice President, Clinical Development & Chief Marketing Officer, Cos To The at PTC Therapeutics, directs the advancement of clinical trials and the global marketing strategy for the company's therapeutic pipeline. Ngumah oversees the transition of small molecule drugs from research phases to commercial availability. By aligning clinical development milestones with market positioning, the Vice President, Clinical Development & Chief Marketing Officer, Cos To The ensures that new treatments effectively address the needs of patients with nonsense mutation Duchenne muscular dystrophy. Quintus Ngumah also manages the development of educational campaigns to increase awareness of post-transcriptional control processes. This leadership role involves collaborating with regulatory bodies to secure product approvals and market access. Through the integration of clinical data into marketing narratives, Ngumah drives the successful adoption of the company's lead products. The Vice President, Clinical Development & Chief Marketing Officer, Cos To The maintains a focus on delivering high-value medical solutions to global markets.